-
Finerenone
API’s Name CAS No. US DMF Patent Expiry Date (US) Current Status Finerenone 1050477-31-0 Apr.12, 2029 PV Completion [Indication]
It is indicated to reduce the risk of sustained eGFR decline, progression to end-stage kidney disease (ESKD), cardiovascular death, nonfatal myocardial infarction, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes.
-
Folic Acid
API’s Name CAS No. US DMF Patent Expiry Date (US) Current Status Folic Acid 59-30-3 Commercial Production [Indication]
1. For the treatment of Folic Acid deficiency megaloblastic anemia, and of pregnancy and infancy.
2. For the treatment of hyperhomocysteinemia.